BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Hemispherx Biopharma (HEB) Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola 10/20/2014 1:47:45 PM
Hemispherx Biopharma (HEB) Prevails In Multi-Million Dollar Federal Lawsuit 10/20/2014 7:24:38 AM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
Hemispherx Biopharma (HEB) Director Dr. William Mitchell To Present Research On Treating Deadly Emerging Viruses During The 4th World Congress On Virology October 8 10/7/2014 7:52:29 AM
Hemispherx Biopharma (HEB) Expands Research On Potential Ebola Treatments To Five Independent Experts/Institutional Collaborators 9/29/2014 8:05:44 AM
Hemispherx Biopharma (HEB) Announces Primate Research Showing Alferon® LDO Protection From Pulmonary Damage Associated With Infection By Highly Pathogenic Influenza Virus 9/22/2014 8:00:57 AM
Hemispherx Biopharma (HEB)' Drug Ampligen Plus Intranasal Seasonal Influenza Vaccine Induces Cross-Reactive Antibody Formation Against Avian H5N1 And H7N9 Influenza HA In Humans 9/15/2014 8:11:04 AM
Hemispherx Biopharma (HEB) And The Swiss Department Of Defense, Civil Protection And Sports Expand Their Collaborative Research Agreement To Include The Study Of Alferon® And Ampligen® Against The Ebola Virus 9/10/2014 8:12:09 AM
Hemispherx Biopharma (HEB) And United States Army Medical Research Institute Of Infectious Diseases (USAMRIID) Agree To Collaborate In Studying Alferon® And Ampligen® Against The Ebola Virus 9/8/2014 8:00:40 AM
Hemispherx Biopharma (HEB) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th 9/3/2014 7:51:47 AM
12345678910...